About Gurdane Bhutani
Gurdane Bhutani is a director at Ancilia Biosciences.
Form D filings also name Gurdane Bhutani as a managing partner and director at Contraline and a director at Junction Health.
Gurdane Bhutani first appears on SEC filings in 2022.
Experience
This experience comes from Gurdane Bhutani's profile and from SEC filings. For roles taken from filings, the years are when the filings name Gurdane Bhutani in the role, so the role may have started earlier or lasted longer.
Ancilia Biosciences, Inc. Current
Member, Board of Directors
2026 – Present · New York, NY
Develops virus-resistant bacterial therapies for human health and other uses.
YM
Yale School of Management Current
Lecturer in the Practice of Management
2025 – Present
PA
Persist AI Current
Observer, Board of Directors
2025 – Present
JG
Juniper Genomics Current
Observer, Board of Directors
2025 – Present
Junction Health, Inc. Current
Member, Board of Directors
2024 – Present · Denver, CO
Builds and operates infusion centers at community health centers.
VI
Vivodyne Current
Special Projects, Office of the CEO
2024 – Present
TH
Thesis Current
Observer, Board of Directors
2023 – Present
Contraline, Inc. Current
Managing Partner and director
Member, Board of Directors (2020 – Present)
2020 – Present · Charlottesville, VA
Develops investigational contraceptive gel and implants for men.
MC
MBX Capital Current
Co-founder & Managing Partner
2020 – Present
KF
Kauffman Fellows Current
Fellow
2018 – Present
CA
CareRev
Observer, Board of Directors
2019 – 2025
FB
Freedom Biosciences
Observer, Board of Directors
2021 – 2024
AH
Atlas Health
Observer, Board of Directors
2019 – 2024
CM
Cleveland Clinic Lerner College of Medicine
Instructor
2017 – 2021
FU
FundRx
Co-founder & Chief Operating Officer
2015 – 2020
BC
Bain & Company
Associate
2013 – 2015
MS
Morgan Stanley
Summer Analyst
2012
Key Colleagues at Startups
The people Gurdane Bhutani works with at each company, as listed on that company's latest Form D.
Contraline, Inc. · Form D, Jun 10, 2026
Junction Health, Inc. · Form D/A, May 22, 2026
VP
Vincent Polito
Executive officer and director
MV
Matthew Vestal
Chief Commercial Officer and director
JH
Jason Hill
Director
BW
Ben Wiederholt
Chief Executive Officer and director
Ancilia Biosciences, Inc. · Form D, Apr 6, 2026
Rodolphe Barrangou
Co-founder, CSO / Part Time and director
Alexandra Sakatos
Co-founder, CEO and director
DP
Dale Pfost
Director
VS
Vera Schroeder
Director